The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

The launch coincides with March Colorectal Cancer Awareness Month, a global initiative emphasizing the importance of early ...

The global digital PCR market size is calculated at USD 7.82 billion in 2025 and is expected to reach around USD 17.45 ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Gonorrhoea is being flagged as an STD that spreads through unprotected sex. Women may encounter symptoms such as vaginal ...

Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, and it's estimated to increase by 77% to 35 million in 2050. However, study shows that up to 40% of cancers ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

Kapayan assemblywoman Jannie Lasimbang, a breast cancer survivor, has called for all parties to continue the fight against the disease. She said the government, healthcare providers, and communities ...